Nanocrystalline silver, gelatinases and the clinical implications

Burns

Volumn 36, Issue 7, 2010, Pages 965-974

  Widgerow, Alan D ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Burns; Cytotoxicity; Gelatinases; MMP 9; Nanocrystalline silver

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; NANOCRYSTALLINE SILVER; PETROLATUM; SILVER; SILVER NITRATE; STEROID; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; BURN; CELL CULTURE; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; EDEMA; EPITHELIZATION; ERYTHEMA; EXPLANT; FIBROBLAST; HONEY; HUMAN; INFLAMMATION; KERATINOCYTE; MONOLAYER CULTURE; NONHUMAN; REVIEW; SKIN ALLERGY; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTI-INFLAMMATORY AGENTS; BANDAGES; CYTOTOXINS; DISEASE MODELS, ANIMAL; HONEY; HUMANS; MATRIX METALLOPROTEINASES; NANOPARTICLES; SILVER; SKIN; SWINE; WOUND HEALING; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 77957589985     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2010.01.010     Document Type: Review

References (50)

1. U.K. Saarialho-Kere Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers Arch Dermatol Res 290 Suppl 1998 S47 S54
2. M. Madlener, W.C. Parks, and S. Werner Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair Exp Cell Res 242 1998 201 210
3. J.J. Reynolds Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation Oral Dis 2 1996 70 76
4. M.R.K. Dasu, M. Spies, R.E. Barrow, and D.N. Herndon Matrix metalloproteinases and their tissue inhibitors in severely burned children Wound Repair Regen 11 2003 177 180
5. F.F. Fan, and A.J. Bard Chemical, electrochemical, gravimetric, and microscopic studies on antimicrobial silver films J Phys Chem B 106 2002 279 287
6. J.B. Wright, K. Lam, D. Hansen, and R.E. Burrell Efficacy of topical silver against fungal burn wound pathogens Am J Infect Control 27 1999 344 350
7. H.Q. Yin, R. Langford, and R.E. Burrell Comparative evaluation of the antimicrobial activity of ActicoatTM antimicrobial barrier dressing J Burn Care Rehabil 20 3 1999 195 200
8. J.B. Wright, K. Lam, and R.E. Burrell Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment Am J Infect Control 26 6 1998 572 577
9. R.E. Burrell, J.P. Heggers, G.J. Davis, and J.B. Wright Effect of silver coated dressings on animal survival in a rodent burn sepsis model Wounds 11 4 1999 64 71
10. P.L. Taylor, A.L. Ussher, and R.E. Burrell Impact of heat on nanocrystalline silver dressings. Part I. Chemical and biological properties Biomaterials 26 2005 7221 7229
11. M.E. Olson, J.B. Wright, K. Lam, and R.E. Burrell Healing of porcine donor sites covered with silver coated dressings Eur J Surg 166 2000 486 489
12. J.B. Wright, K. Lam, A. Buret, M.E. Olson, and R.E. Burrell Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing Wound Repair Regen 10 2002 141 151
13. J.B. Wright, K. Lam, E.O. Merle, and R.E. Burrell Is antimicrobial efficacy sufficient? A question concerning the benefits of new dressings Wounds 15 5 2003 133 141
14. K.C. Bhol, J. Alroy, and P.J. Schechter Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model International investigative dermatology meeting 2003, Fontainebleau Hilton Miami Beach Florida, April 30-May 4 2003
15. P.L. Nadworny, J.F. Wang, E.E. Tredget, and R.E. Burrell Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model Nanomedicine: NBM 4 2008 241 251
16. R.S. Kirsner, H. Orsted, and J.B. Wright Matrix metalloproteinases in normal and impaired wound healing: a potential role of nanocrystalline silver Wounds 13 3C 2002 4 12
17. V.K.M. Poon, and A. Burd In vitro cytotoxicity of silver: implication for clinical wound care Burns 30 2004 140 147
18. M.E. Innes, N. Umraw, J.S. Fish, M. Gomez, and R.C. Cartotto The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study Burns 27 2001 621 627
19. D.J. Leaper Silver dressings: their role in wound management Int Wound J 3 2006 282 294
20. R.H. Demling, and L. DeSanti The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver Burns 28 2002 264 266
21. A. Burd, C.H. Kwok, M.S.C. Hung, M.H.S. Chan, H. Gu, and M.W.K. Lam A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models Wound Repair Regen 15 2007 94 104
22. M.J. Reiss, Y.-P. Han, and W.L. Garner α1-Antichymotrypsin activity correlates with and may modulate matrix metalloproteinase-9 in human acute wounds Wound Repair Regen 17 3 2009 418 426
23. L. Ravanti, and V.M. Kahari Matrix metalloproteinases in wound repair Int J Mol Med 6 2000 391
24. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827
25. J.M. Fray, R.P. Dickinson, J.P. Huggins, and N.L. Occleston A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers J Med Chem 46 2003 3514 3525
26. A.B. Wysocki, A.O. Kusakabe, S. Chang, and T.L. Tuan Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing Wound Repair Regen 7 1999 154 165
27. G.P. Ladwig, M.C. Robson, R. Liu, M.A. Kuhn, D.F. Muir, and G.S. Schultz Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers Wound Repair Regen 10 2002 26 37
28. E.A. Rayment, Z. Upton, and G.K. Shooter Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer Br J Dermatol 158 2008 951 961
29. W.C. Parks Matrix metalloproteinases in repair Wound Repair Regen 7 1999 423 432
30. R.W. Tarnuzzer, and G.S. Schultz Biochemical analysis of acute and chronic wound environments Wound Repair Regen 4 1996 321 325
31. Y. Okada, Y. Gonoji, K. Naka, K. Tomita, I. Nakanishi, and K. Iwata Matrix metalloproteinase-9 (92-kDa gelatinase type-IV collagenase) from Ht-1080 human fibrosarcoma cells - purification and activation of the precursor and enzymatic properties J Biol Chem 267 21 1992 712 719
32. B. Cullen, R. Smith, E. McCulloch, D. Silcock, and L. Morrison Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers Wound Repair Regen 10 2002 16 25
33. M. Madlener Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds Arch Dermatol Res 290 Suppl 1998 24 29
34. J.F. Tarlton, C.J. Vickery, D.J. Leaper, and A.J. Bailey Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9 Br J Dermatol 137 1997 506 516
35. R. Mohan, S.K. Chintala, J.C. Jung, W.V. Villar, F. McCabe, and L.A. Russo Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration J Biol Chem 277 2002 2065 2072
36. N.J. Trengove, M.C. Stacey, S. Macauley, N. Bennett, J. Gibson, and F. Burslem Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors Wound Repair Regen 7 1999 442
37. M.S. gren, U. Mirastschijski, T. Karlsmark, and U.K. Saarialho-Kere Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds Exp Dermatol 10 2001 337 348
38. G.S. Ashcroft, M.A. Horan, S.E. Herrick, R.W. Tarnuzzer, G.S. Schultz, and M.W. Ferguson Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans Cell Tissue Res 290 1997 581 591
39. K. Dunn, V. Edwards-Jones, The role of Acticoat™ with nanocrystalline silver in the management of burns Burns 30 Suppl 1 2004
40. J.B. Wright, D.L. Hansen, and R.E. Burrell The comparative efficacy of two antimicrobial barrier dressings: in vitro examination of two controlled-release silver dressings Wounds 10 1998 179 188
41. Thomas S. MRSA and the use of silver dressings: overcoming bacterial resistance. World Wide Wounds. November. 2004. (www.worldwidewounds.com ).
42. I.A. Holder, P. Durkee, A.P. Supp, and S.T. Boyce Assessment of a silver coated barrier dressing for potential use with skin grafts on excised burns Burns 29 2003 445 448
43. E.E. Tredget, H.A. Shankowsky, A. Groenveld, and R.E. Burrell A matched-pair, randomised study evaluating the efficacy and safety of Acticoat nanocrystalline silver dressing for the treatment of burn wounds J Burn Care Rehabil 19 1998 531 537
44. M. Ip, S.L. Lui, V.K.M. Poon, and A. Burd Antimicrobial activities of silver dressings: an in vitro comparison J Med Microbiol 55 2006 59 63
45. R. Strohal, M. Schelling, M. Takacs, W. Jurecka, U. Gruber, and F. Offner Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem J Hosp Infect 60 2005 226 230
46. R.E. Burrell, J.P. Heggers, G.J. Davis, and J.B. Wright Efficacy of a silver coated dressing as bacterial barriers in a rodent burn sepsis model Wounds 11 1999 64 71
47. P.A. Maple, J.M. Hamilton-Miller, and W. Brumfitt Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillinresistant Staphylococcus aureus J Antimicrobial Chemotherapy 29 1992 661 668
48. C.N. Serhan, and J. Savil Resolution of inflammation: the beginning programs the end Nat Immunol 6 2005 1191 1197
49. C. Wiegand, T. Heinze, and U.-C. Hipler Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate Wound Repair Regen 17 2009 511 521
50. D.F. du Toit, and B.J. Page An in vitro evaluation of the cell toxicity of honey and silver dressings J Wound Care 8, 9 2009 383 389